Investigations of differences in iron oxidation state inside single neurons from substantia nigra of Parkinson's disease and control patients using the micro-XANES technique

Journal of Biological Inorganic Chemistry

Volumn 12, Issue 2, 2007, Pages 204-211

  Chwiej, Joanna ^a   Adamek, Dariusz ^b   Szczerbowska Boruchowska, Magdalena ^a   Krygowska Wajs, Anna ^b   Wojcik, Slawomir ^a   Falkenberg, Gerald ^c   Manka, Anna ^a   Lankosz, Marek ^a  

^a AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c DESY   (Germany)

Author keywords

Iron oxidation state; Parkinson's disease; Single cell; X ray absorption near edge structure spectroscopy

Indexed keywords

FERRIC ION; IRON; PARAFFIN;

ABSORPTION SPECTROSCOPY; ADULT; AGED; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NERVE CELL; OXIDATION; PARKINSON DISEASE; PERIKARYON; PRIORITY JOURNAL; SUBSTANTIA NIGRA; X RAY ANALYSIS;

HUMANS; IRON; NEURONS; OXIDATION-REDUCTION; PARKINSON DISEASE; SPECTROMETRY, X-RAY EMISSION; STAINING AND LABELING; SUBSTANTIA NIGRA;

EID: 33846659146     PISSN: 09498257     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00775-006-0179-5     Document Type: Article

References (45)

1. Samii A, Nutt JG, Ransom BR (2004) Lancet 363:1783-1793
2. Kaur D, Andersen J (2004) Ageing Res Rev 3:327-343
3. Bharath S, Hsu M, Kaur D, Rajagopalan S, Andersen JK (2002) Biochem Pharmacol 64:1037-1048
4. Adams JD, Chang ML, Klaidman L (2001) Curr Med Chem 8:809-814
5. Foley P, Riederer PJ (2000) Neurol 247(Suppl 2):82-94
6. Andersen JK (2004) J Alzheimer Dis 6:47-52
7. Gotz ME, Double K, Gerlach M, Youdim MB, Riederer P (2004) Ann N Y Acad Sci 1012:193-208
8. Wolozin B, Golts N (2002) Neuroscientist 8:22-32
9. Galazka-Friedman J, Bauminger ER, Friedman A (2002) Hyperfine Interact 2:67-271
10. Antonini A, Leenders KL, Meier D, Oertel WH, Boesiger P, Anliker M (1993) Neurology 43:697-700
11. Zecca L, Berg D, Arzberger T, Ruprecht P, Rausch WD, Musicco M, Tampellini D, Riederer P, Gerlach M, Becker G (2005) Mov Disord 20:1278-1285
12. Berg D, Hochstrasser H, Schweitzer KJ, Riess O (2006) Neurotox Res 9:1-13
13. Griffiths PD, Dobson BR, Jones GR, Clarke DT (1999) Brain 122:667-673
14. Sofic E, Riederer P, Heinsen H, Beckmann H, Reynolds GP, Hebenstreit G, Youdim MB (1988) J Neural Transm 74:199-205
15. Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MB (1991) J Neurochem 56:978-982
16. Morawski M, Meinecke C, Reinert T, Dorffel AC, Riederer P, Arendt T, Butz T (2005) Nucl Instrum Methods Phys Res Sect B 231:224-228
17. Friedman A, Bauminger ER, Galazka-Friedman J, Barcikowska M, Suwalski J, Hechel D, Dymecki J, Nowik I (1994) Neurol Neurochir Pol 28:145-155
18. Galazka-Friedman J, Bauminger ER, Friedman A, Barcikowska M, Hechel D, Nowik I (1997) Mov Disord 12:258-260
19. Costello DJ, Walsh SL, Harrington HJ, Walsh CH (2004) J Neurol Neurosurg Psychiatry 75:631-633
20. Nielsen JE, Jensen LN, Krabbe KJ (1995) Neurol Neurosurg Psychiatry 59:318-321
21. Dekker MC, Giesbergen PC, Njajou OT, van Swieten JC, Hofman A, Breteler MM, van Duijn CM (2003) Neurosci Lett 348:117-119
22. Zucca FA, Giaveri G, Gallorini M, Albertini A, Toscani M, Pezzoli G, Lucius R, Wilms H, Sulzer D, Ito S, Wakamatsu K, Zecca L (2004) Pigment Cell Res 17:610-617
23. Gerlach M, Double KL, Ben-Shachar D, Zecca L, Youdim MB, Riederer P (2003) Neurotox Res 5:35-44
24. Faucheux BA, Martin ME, Beaumont C, Hauw JJ, Agid Y, Hirsch EC (2003) J Neurochem 86:1142-1148
25. Zecca L, Zucca F, Wilms H, Sulzer D (2003) Trends Neurosci 26:578-580
26. Newville M (2003) Fundamentals of XAFS. http://www.xafs.org/Tutorials/ #references
27. Bare SR (2005) EXAFS data collection and analysis course. http://www.cars9.uchicago.edu/xafs/APS_2005/Bare_XANES.pdf
28. Koningsberger DC, Prins R (eds) (1988) X-ray absorption: principles, applications, techniques of EXAFS, SEXAFS, and XANES. Wiley, New York
29. Parsons JG, Aldrich MV, Gardea-Torresdey JL (2002) Appl Spectrosc Rev 37:187-222
30. Ascone I, Cognigni A, Giorgetti M, Berrettoni M, Zamponi S, Marassi RJ (1999) Synchrotron Radiat 6:384-386
31. Sarkar BJ (2000) Inorg Biochem 79:187-191
32. Gunter KK, Miller LM, Aschner M, Eliseev R, Depuis D, Gavin CE, Gunter TE (2002) Neurotoxicology 23:127-146
33. Nicolis I, Curis E, Deschamps P, Benazeth SJ (2003) Synchrotron Radiat 10:96-102
34. Yoshida S, Ektessabi A, Fujisawa S (2001) J Synchrotron Radiat 8:998-1000
35. Ide-Ektessabi A, Kawakami T, Watt F (2004) Nucl Instrum Methods Phys Res Sect B 213:590-594
36. Yoshida S, Ide-Ektessabi A, Fujisawa S (2003) Struct Chem 14:85-95
37. Chwiej J, Szczerbowska-Boruchowska M, Lankosz M, Wojcik S, Falkenberg G, Stegowski Z, Setkowicz Z (2005) Spectrochim Acta Part B 60:1531-1537
38. Bobrański B (1966) Chemia organiczna. 3rd edn. PWN, Warsaw
39. Falkenberg G, Clauss O, Tschentscher T (2001) Hasylab annual report. http://www-hasylab.desy.de/science/annual_reports/2001_report/index.html
40. Ortega R, Deves G, Bohic S, Simionovici A, Menez B, Bonnin-Mosbah M (2001) Nucl Instrum Methods Phys Res Part B 181:480-484
41. Ektessabi A, Shikine S, Kitamura N, Rokkum M, Johansson C (2001) X-Ray Spectrom 30:44-48
42. Sugimoto T, Ide-Ektessabi A, Ishihara R; Tanigaki M (2004) J Electron Spectrosc Relat Phenom 137-140:831-838
43. Wilke M, Farges F, Petit PE, Brown GE (2001) Am Mineral 86:714-730
44. Galazka-Friedman J, Bauminger ER, Friedman A, Barcikowska M, Hechel D, Nowik I (1997) Mov Disord 12:258-260
45. Gerlach M, Ben-Shachar D, Riederer P, Youdim MBH (1994) J Neurochem 63:793-807